Evaluation of the In Vitro Antifungal Activity of Novel Arylsulfonamides against Candida spp.

The antifungal activity of molecules belonging to the arylsulfonamide chemotype has previously been demonstrated. Here, we screened arylsulfonamide-type compounds against a range of Candida spp. and further established the structure-activity relationship based on a "hit compound". A series of four sulfonamide-based compounds, N-(4-sulfamoylbenzyl) biphenyl-4-carboxamide ( 3 ), 2,2-diphenyl-N-(4-sulfamoylbenzyl) acetamide ( 4 ), N-(4-sulfamoylphenethyl) biphenyl-4-carboxamide ( 5 ) and 2,2-diphenyl-N-(4-sulfamoylphenethyl) acetamide ( 6 ), were tested against the American Type Culture Collection (ATCC) and clinical strains of C. albicans , C. parapsilosis and C. glabrata . Based on the fungistatic potential of prototype 3 , a further subset of compounds, structurally related to hit compound 3 , was synthesized and tested: two benzamides ( 10 - 11 ), the related amine 4-[[(4-4-((biphenyl-4-ylmethylamino)methyl) benzenesulfonamide ( 13 ) and the corresponding hydrochloride, 13 . HCl . Both amine 13 and its hydrochloride salt had fungicidal effects against Candida glabrata strain 33 (MFC of 1.000 mg/mL). An indifferent effect was detected in the association of the compounds with amphotericin B and fluconazole. The cytotoxicity of the active compounds was also evaluated. This data could be useful to develop novel therapeutics for topical use against fungal infections.